S. E. Salmon
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Erythropoietin and Anemia Treatment
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
Papers in
- Hematology 15
- Multiple Myeloma Research and Treatments 13
- Oncology 16
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 2
- Co-authors
- Stephen E. JonesWilliam S. DaltonThomas M. GroganR J ScheperTP MillerCatherine SpierH. Hugh FudenbergDavid S. Alberts
- Journals
- Journal of Clinical Oncology (7 papers)JNCI Journal of the National Cancer Institute (3 papers)The Lancet (3 papers)Journal of Pharmaceutical Sciences (2 papers)Recent results in cancer research (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
S. E. Salmon
39 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 99
- Hematology 533
- Oncology 949
- Genetics 151
- Immunology 215
- Cancer Research 143
Countries citing papers authored by S. E. Salmon
This map shows the geographic impact of S. E. Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Salmon more than expected).
Fields of papers citing papers by S. E. Salmon
This network shows the impact of papers produced by S. E. Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Salmon. The network helps show where S. E. Salmon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. E. Salmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 4 | |
| 2 | 2019 | 1 | |
| 3 | 1997 | 0 | |
| 4 | Transplants for multiple myeloma | 1995 | 10 |
| 5 | 1993 | 154 | |
| 6 | 1991 | 328 | |
| 7 | A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin. | 1991 | 29 |
| 8 | 1989 | 178 | |
| 9 | 1989 | 39 | |
| 10 | 1988 | 12 | |
| 11 | 1987 | 38 | |
| 12 | 1987 | 6 | |
| 13 | Human tumor cloning: drug sensitivity testing clinical correlations. | 1982 | 4 |
| 14 | Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study. | 1982 | 27 |
| 15 | 1982 | 12 | |
| 16 | Therapeutic strategies in multiple myeloma. | 1980 | 4 |
| 17 | Adjuvant therapies of the various primary tumors | 1979 | 2 |
| 18 | 1978 | 78 | |
| 19 | Failure of indium 111-labeled bleomycin tumor scanning to predict response to bleomycin (NSC-125066) treatment. | 1975 | 4 |
| 20 | 1971 | 6 |
About S. E. Salmon
S. E. Salmon is a scholar working on Hematology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Toxicology, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Cancer Treatment and Pharmacology (9 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Protein Degradation and Inhibitors (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer therapeutics and mechanisms (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Hematology (533 citations), Oncology (949 citations), Genetics (151 citations), Immunology (215 citations) and Cancer Research (143 citations). S. E. Salmon has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Stephen E. Jones, William S. Dalton, Thomas M. Grogan, R J Scheper, TP Miller, Catherine Spier, H. Hugh Fudenberg, David S. Alberts, Teruko Ishizaka and Kimishige Ishizaka. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, The Lancet, Journal of Pharmaceutical Sciences and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.